Our services
Robotics and Laboratories,
designed for science.
At Neveso, we architect next-generation laboratory environments for science-driven organizations.
We deliver consulting and engineering services through a complete, integrated range of expertise.
By bridging humans, processes, and technologies, we transform scientific ambitions into operational laboratories.
Let your team focus on science and operations, while we integrate advanced robotic technologies across your sites.
An end-to-end approach to Laboratory Transformation.
01 Value Analysis & Strategy
NEVESO brings strategic insight from day one.
Identify where laboratory transformation creates real scientific and business value.
- In-depth analysis of laboratory processes and operating models
- Technical studies and solution benchmarking
- ROI analysis and compliance exposure assessment
- Pre-definition of scope, budget, timelines, and resources
- Strategic support to build management-level business cases
02 Concept Study & Design
NEVESO aligns scientific ambitions with practical execution.
Design laboratory solutions aligned with science, operations, and compliance.
- Identification of the robotic use cases and user requirements (URS)
- Definition of robotics, automation, equipment and digital integration
- Laboratory architecture and IT/OT integration mapping
- Technical and regulatory risk assessments
- CAPEX / OPEX modeling
03 Solution Validation
NEVESO turns concepts into actionable plans.
Validate the laboratory architecture before execution begins.
- End-to-end laboratory design deliverables
- Coordination of technical specifications and integration points
- Supplier alignment and resource planning
- Contract structuring and performance safeguards
04 Project Execution & Integration
NEVESO delivers end-to-end project management aligning all stakeholders.
Drive project from kick-off to go-live.
- Full project management and governance
- Coordination of suppliers and client stakeholders
- Installation, FAT/SAT, and commissioning of robotic systems
- Integration of digital interfaces and middleware
- Budget, risk, and resource management throughout the project lifecycle
05 Qualification & Compliance
NEVESO secures compliance while accelerating delivery.
Deliver laboratories that are validated, documented, and inspection-ready.
- CQV and CSV strategy definition and execution
- Development and ownership of validation documentation (URS, IQ, OQ, PQ)
- Data integrity, audit trail, and 21 CFR Part 11 support
- Validation of digital components linked to laboratory systems
- Risk-based qualification adapted to GMP / non-GMP environments
06 Training & Handover
NEVESO empowers clients across laboratory processes, systems, and operations.
Ensure autonomy through structured knowledge transfer.
- SOP development and operational documentation
- Operational and compliance training
- Knowledge transfer to clients’ teams
- Controlled go-live and hypercare period
07 Maintenance Strategy & Lifecycle Planning
NEVESO ensure reliability today and readiness for tomorrow.
Secure long-term laboratory performance, maximize uptime, and ensure future readiness.
- Definition of maintenance strategies (Levels 1, 2, and 3) with client teams
- Structuring and negotiation of maintenance and support contracts with suppliers
- Operational maintenance support by NEVESO experts for specific laboratory applications
- Lifecycle roadmaps covering upgrades, scalability, obsolescence management, and future technologies
Our vision
Visionary laboratory programs emerge when science, engineering, and project governance move in the same direction.
Having these disciplines in-house is a challenge for most organizations.
NEVESO brings these disciplines into one integrated offering.
One Partner,
Full Journey
From early strategy to
operational laboratories.
For Science
and Operations
Solutions aligned with scientific
goals, operational constraints,
and regulatory environments.
Value-Driven
Outcomes
Scientists focus on discovery.
Decision-makers gain
transparency and control.
Proven Where
It Matters
Trusted by leaders in Pharma,
Biotech, and MedTech.
